Start Date

7-6-2011 2:15 PM

End Date

7-6-2011 3:00 PM

Description

Thomas J. Walsh, MD, FACP, FCCP, FAAM, FISDA, is Professor of Medicine (appointment pending) and Director of the new Transplantation-Oncology Infectious Diseases Program at Weill Medical College of Cornell University. Following graduation from Johns Hopkins University School of Medicine, Dr. Walsh completed ten post-doctoral years of laboratory investigation, clinical research and patient care leading to boards in Medicine, Infectious Diseases and Oncology and laboratory expertise in pharmacology, innate host defenses, and medical mycology.

Following a distinguished career in the Pediatric Oncology Branch of the National Cancer Institute, Dr. Walsh was recruited to direct the new Transplantation-Oncology Infectious Diseases Program of Weill Medical College of Cornell University and the New York Presbyterian Hospital. The mission of the Program is to provide leading edge multidisciplinary clinical care, translational research and training in diagnosis, treatment and prevention of life-threatening infections in immunocompromised patients with transplantation or cancer. Current laboratory and clinical investigations include antimicrobial pharmacology, immunopharmacology of innate host defense, and molecular diagnosis of emerging fungal, bacterial and viral pathogens in immunocompromised patients.

walsh.mp3 (33891 kB)
Audio of presentation-Runs 37 minutes

Included in

Public Health Commons

Share

COinS
 
Jun 7th, 2:15 PM Jun 7th, 3:00 PM

Adoption of Protective Uniforms

Thomas J. Walsh, MD, FACP, FCCP, FAAM, FISDA, is Professor of Medicine (appointment pending) and Director of the new Transplantation-Oncology Infectious Diseases Program at Weill Medical College of Cornell University. Following graduation from Johns Hopkins University School of Medicine, Dr. Walsh completed ten post-doctoral years of laboratory investigation, clinical research and patient care leading to boards in Medicine, Infectious Diseases and Oncology and laboratory expertise in pharmacology, innate host defenses, and medical mycology.

Following a distinguished career in the Pediatric Oncology Branch of the National Cancer Institute, Dr. Walsh was recruited to direct the new Transplantation-Oncology Infectious Diseases Program of Weill Medical College of Cornell University and the New York Presbyterian Hospital. The mission of the Program is to provide leading edge multidisciplinary clinical care, translational research and training in diagnosis, treatment and prevention of life-threatening infections in immunocompromised patients with transplantation or cancer. Current laboratory and clinical investigations include antimicrobial pharmacology, immunopharmacology of innate host defense, and molecular diagnosis of emerging fungal, bacterial and viral pathogens in immunocompromised patients.